Filing Details
- Accession Number:
- 0001181431-11-010890
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-16 17:37:18
- Reporting Period:
- 2011-02-15
- Filing Date:
- 2011-02-16
- Accepted Time:
- 2011-02-16 17:37:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1011835 | Medivation Inc. | MDVN | Pharmaceutical Preparations (2834) | 133863260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1327111 | Lynn Seely | C/O Medivation, Inc. 201 Spear Street, 3Rd Floor San Francisco CA 94105 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-02-15 | 50,000 | $3.60 | 66,666 | No | 4 | M | Direct | |
Common Stock | Disposition | 2011-02-15 | 50,000 | $17.97 | 16,666 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2011-02-15 | 50,000 | $0.00 | 50,000 | $3.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
116,000 | 2015-03-14 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a 10b5-1 Plan.
- The shares were sold at prices between $17.50 and $18.355. The Reporting Person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The option is immediately exercisable, in whole or in part, and the shares subject to the option vest according to the following schedule: 25% of the shares subject to the option vested on March 14, 2006, and 1/48th of the shares subject to the option vested and continue to vest on the first day of each full month thereafter so that all of the shares subject to the option shall be fully vested on March 1, 2009.